NorFalk
PrivateLast Round
Convertible Debt
Mar 7, 2024
Total Funding Raised
$1.98M
Company Overview
NorFalk is a biotechnology company that develops and produces sustainable, bio-based surfactants as alternatives to fossil-derived or palm oil-based ingredients for the cosmetics and personal care industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorFalk Comparables
Compare NorFalk with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AmphiStar | 86% | |
| Holiferm | 83% | |
| Dispersa | 83% | |
NorFalk Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 7, 2024 | ||||
| Pre Seed | Jun 1, 2023 |
Key People
Founding team and executive leadership
NorFalk Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemstars | Pre Seed |
| BioInnovation Institute | Pre Seed, Convertible Debt |
NorFalk Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NorFalk's valuation, stock price, and market status.